• Mashup Score: 0

    Submission Deadline: Monday, December 11, 2023 at 11:59PM ET Anesthesia and Perioperative Management Aortic Arch Aortic Root Aortic Surgery Forum (Basic Aortic Research; Venue for Residents, Fellows, Junior Attendings) Ascending Aorta Cerebral Protection Descending/Thoracoabdominal Aorta Dissection Endoluminal Prostheses Genetics of Aortic Disease Natural History/Follow-Up Other Spinal Cord Protection Trauma Decisions of the Program Committee will be made known to all presenting authors by email in late

    Tweet Tweets with this article
    • Ready to present your research? Submit now to #Aortic2024, the two-day event focused on the #pathophysicology, diagnosis and treatment of #aortic aneurysms and #dissections. Deadline: December 11. https://t.co/PCchX9zjjv https://t.co/Gu3gvKjY8d

  • Mashup Score: 1

    Rather than a ‘bailout’ procedure for the chimney technique, EnChEVAR could become a standardized, therapeutic, complementary option.

    Tweet Tweets with this article
    • The use of EnChEVAR could change the view of physicians regarding the chimney technique, says Dr. Konstantinos Donas, who specializes in the evaluation and evolution of the chimney/snorkel #endovascular technique in treating complex #aortic #aneurysms. https://t.co/YyDkniJ3m8 https://t.co/p4N0L5IplV

  • Mashup Score: 0

    July 21, 2023 — Onecrea Medical has announced the success of the first-in-human implants of its Transcatheter Aortic Valve Replacement (TAVR) system for the treatment of aortic stenosis. While TAVR technology has been around since 2007, Onecrea Medical’s team of scientists and engineers worked towards creating a next-generation TAVR. A common complication with the TAVR/ procedures is dislodging of the implant or perivalvular leak (PVL) due to an improper fit of the valve. Onecrea Medical’s valve has a unique concave and convex structure that anchors the valve effectively in the aortic annulus. The valve also features differential radial force in different parts, imparting low or high radial forces to the valve depending on the location within the annulus and aorta. In addition, the delivery system has been improved for greater control and accuracy of valve implantation. Crea Aortic valves are rigorously tested for over 200 million fatigue cycles and over 140 days in animal trials. Thes

    Tweet Tweets with this article
    • @DAICeditor #OnecreaMedical has announced the success of the first-in-human implants of its #Transcatheter #Aortic #Valve Replacement (#TAVR) system for the treatment of #aorticstenosis: https://t.co/TZDGUwzz4P